Disulfiram ameliorates nonalcoholic steatohepatitis by modulating the gut microbiota and bile acid metabolism
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Disulfiram ameliorates nonalcoholic steatohepatitis by modulating the gut microbiota and bile acid metabolism
Authors
Keywords
-
Journal
Nature Communications
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-11-12
DOI
10.1038/s41467-022-34671-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- COVID-19 and related symptoms in patients under disulfiram for alcohol use disorder
- (2021) Stefano Tamburin et al. Internal and Emergency Medicine
- Seesaw conformations of Npl4 in the human p97 complex and the inhibitory mechanism of a disulfiram derivative
- (2021) Man Pan et al. Nature Communications
- Management of non-alcoholic fatty liver disease
- (2021) Maria Letizia Petroni et al. BMJ-British Medical Journal
- Therapeutic pipeline in nonalcoholic steatohepatitis
- (2021) Raj Vuppalanchi et al. Nature Reviews Gastroenterology & Hepatology
- The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer
- (2021) Lulu Sun et al. Nature Reviews Gastroenterology & Hepatology
- Drug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent
- (2021) Debbie-Ann Shirley et al. Frontiers in Cellular and Infection Microbiology
- Mechanisms and disease consequences of nonalcoholic fatty liver disease
- (2021) Rohit Loomba et al. CELL
- Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3
- (2021) Francesco Beghini et al. eLife
- Antibacterial Effects of Disulfiram in Helicobacter pylori
- (2021) Tomomi Kobatake et al. Infection and Drug Resistance
- Parabacteroides produces acetate to alleviate heparanase-exacerbated acute pancreatitis through reducing neutrophil infiltration
- (2021) Yuanyuan Lei et al. Microbiome
- Advancing the global public health agenda for NAFLD: a consensus statement
- (2021) Jeffrey V. Lazarus et al. Nature Reviews Gastroenterology & Hepatology
- Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
- (2021) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties
- (2020) Yuya Terashima et al. Nature Communications
- Disulfiram Treatment Normalizes Body Weight in Obese Mice
- (2020) Michel Bernier et al. Cell Metabolism
- Nonalcoholic Steatohepatitis
- (2020) Adam C. Sheka et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- PICRUSt2 for prediction of metagenome functions
- (2020) Gavin M. Douglas et al. NATURE BIOTECHNOLOGY
- Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis
- (2020) Stephen A. Harrison et al. GASTROENTEROLOGY
- Intestinal microbiota regulates anti‐tumor effect of disulfiram combined with Cu 2+ in a mice model
- (2020) Hong Hu et al. Cancer Medicine
- Gut microbial metabolites as multi-kingdom intermediates
- (2020) Kimberly A. Krautkramer et al. NATURE REVIEWS MICROBIOLOGY
- Current Concepts, Opportunities, and Challenges of Gut Microbiome-Based Personalized Medicine in Nonalcoholic Fatty Liver Disease
- (2020) S.R. Sharpton et al. Cell Metabolism
- Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome
- (2020) Oren Rom et al. Science Translational Medicine
- Disulfiram, an alcohol dependence therapy, can inhibit the in vitro growth of Francisella tularensis
- (2019) Karleigh A. Hamblin et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Bacterial Metabolism and Antibiotic Efficacy
- (2019) Jonathan M. Stokes et al. Cell Metabolism
- Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2
- (2019) Evan Bolyen et al. NATURE BIOTECHNOLOGY
- The ‘in vivo lifestyle’ of bile acid 7α-dehydroxylating bacteria: comparative genomics, metatranscriptomic, and bile acid metabolomics analysis of a defined microbial community in gnotobiotic mice
- (2019) Jason M. Ridlon et al. Gut Microbes
- Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism
- (2019) Fengjie Huang et al. Nature Communications
- Histological improvement of non-alcoholic steatohepatitis with a prebiotic: a pilot clinical trial
- (2018) Marc R. Bomhof et al. EUROPEAN JOURNAL OF NUTRITION
- Lipotoxicity and the gut-liver axis in NASH pathogenesis
- (2018) Fabio Marra et al. JOURNAL OF HEPATOLOGY
- Tomato Powder Inhibits Hepatic Steatosis and Inflammation Potentially Through Restoring SIRT1 Activity and Adiponectin Function Independent of Carotenoid Cleavage Enzymes in Mice
- (2018) Cheng-Chung Li et al. MOLECULAR NUTRITION & FOOD RESEARCH
- The gut–liver axis and the intersection with the microbiome
- (2018) Anupriya Tripathi et al. Nature Reviews Gastroenterology & Hepatology
- Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells
- (2018) Chi Ma et al. SCIENCE
- Diethyldithiocarbamate, an anti-abuse drug, alleviates steatohepatitis and fibrosis in rodents through modulating lipid metabolism and oxidative stress
- (2018) Tianhui Liu et al. BRITISH JOURNAL OF PHARMACOLOGY
- The role of the microbiome in NAFLD and NASH
- (2018) Aleksandra A Kolodziejczyk et al. EMBO Molecular Medicine
- GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease
- (2018) Rohit Loomba et al. GASTROENTEROLOGY
- The Gene Ontology Resource: 20 years and still GOing strong
- (2018) NUCLEIC ACIDS RESEARCH
- Interactions between gut bacteria and bile in health and disease
- (2017) Sarah L. Long et al. MOLECULAR ASPECTS OF MEDICINE
- Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4
- (2017) Zdenek Skrott et al. NATURE
- Fructo-oligosaccharides and intestinal barrier function in a methionine–choline-deficient mouse model of nonalcoholic steatohepatitis
- (2017) Kotaro Matsumoto et al. PLoS One
- Human Microbiota-Associated Mice: A Model with Challenges
- (2016) Marie-Claire Arrieta et al. Cell Host & Microbe
- Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives
- (2016) Juan P. Arab et al. HEPATOLOGY
- Using an Old Drug to Target a New Drug Site: Application of Disulfiram to Target the Zn-Site in HCV NS5A Protein
- (2016) Yu-Ming Lee et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- DADA2: High-resolution sample inference from Illumina amplicon data
- (2016) Benjamin J Callahan et al. NATURE METHODS
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction
- (2015) Changtao Jiang et al. Nature Communications
- Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study
- (2015) Julian H Elliott et al. Lancet HIV
- UniRef clusters: a comprehensive and scalable alternative for improving sequence similarity searches
- (2014) B. E. Suzek et al. BIOINFORMATICS
- Trimmomatic: a flexible trimmer for Illumina sequence data
- (2014) Anthony M. Bolger et al. BIOINFORMATICS
- STAMP: statistical analysis of taxonomic and functional profiles
- (2014) Donovan H. Parks et al. BIOINFORMATICS
- Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal
- (2014) Johannes Schmitt et al. LIVER INTERNATIONAL
- Alterations of the human gut microbiome in liver cirrhosis
- (2014) Nan Qin et al. NATURE
- Fast and sensitive protein alignment using DIAMOND
- (2014) Benjamin Buchfink et al. NATURE METHODS
- Amelioration of hepatic inflammation in a mouse model of NASH using a dithiocarbamate derivative
- (2013) Jason J. Schwartz et al. Hepatology International
- Antitubercular Activity of Disulfiram, an Antialcoholism Drug, against Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Isolates
- (2012) Yasuhiro Horita et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacogenetic Randomized Trial for Cocaine Abuse: Disulfiram and Dopamine β-Hydroxylase
- (2012) Thomas R. Kosten et al. BIOLOGICAL PSYCHIATRY
- Fast gapped-read alignment with Bowtie 2
- (2012) Ben Langmead et al. NATURE METHODS
- The SILVA ribosomal RNA gene database project: improved data processing and web-based tools
- (2012) Christian Quast et al. NUCLEIC ACIDS RESEARCH
- Oxidation of the Guanine Nucleotide Pool Underlies Cell Death by Bactericidal Antibiotics
- (2012) J. J. Foti et al. SCIENCE
- Metagenomic biomarker discovery and explanation
- (2011) Nicola Segata et al. GENOME BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now